Xilong Scientific Co. Ltd. cancelled the acquisition of an 80% stake in MIVIP Healthcare Holdings LLC from Shanghai Hongxiao Technology Co., Ltd.
August 09, 2019
Share
Xilong Scientific Co. Ltd. (SZSE:002584) agreed to acquire an 80% stake in MIVIP Healthcare Holdings LLC from Shanghai Hongxiao Technology Co., Ltd. on August 10, 2018. KPMG China served as the financial advisor to Xilong Scientific Co. Ltd. in connection with the deal.
Xilong Scientific Co. Ltd. (SZSE:002584) cancelled the acquisition of an 80% stake in MIVIP Healthcare Holdings LLC from Shanghai Hongxiao Technology Co., Ltd. on August 10, 2019.
XILONG SCIENTIFIC CO.,LTD., formerly XILONG CHEMICAL CO.,LTD., is principally engaged in the research, development, production and sale of chemical reagents. The Company primarily provides general chemical reagents, including ammonia water, sodium hydroxide, sulfuric acid, nitric acid, carbinol and ethanol; chemical reagents for printed circuit boards (PCBs), as well as super clean high purity chemical reagents. Its chemical reagents are mainly used in electronic information, daily chemicals, medicine, food, as well as sensitization industries. The Company is also involved in chemical raw material, bulk pharmaceutical, food additive, and in-vitro diagnostic substance businesses.